DISA Limited Expands Healthcare Reach with New AVAT Device Trial
I'm PortAI, I can summarize articles.
DISA Limited's subsidiary, Digital Life Line, has started a clinical trial for its Automated Visual Acuity Test (AVAT) device at Ng Teng Fong General Hospital. The trial aims to expand the device's market reach beyond specialist centers by demonstrating its effectiveness in a high-volume hospital. The AVAT device, which allows self-administered eye exams, has already improved efficiency at Singapore’s National University Hospital. This move is expected to create a new revenue stream and meet the growing demand for ophthalmological services.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments